# DALBAVANCIN HYDROCHLORIDE
> **ANDA218929** · Abbreviated New Drug Application (Generic) · Sponsor: KINDOS · Approved 2025-11-26
## Drug
- **FDA Application Number:** ANDA218929
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DALBAVANCIN HYDROCHLORIDE
- **Generic name:** DALBAVANCIN
- **Active ingredients:** DALBAVANCIN HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** KINDOS
- **Manufacturer:** Meitheal Pharmaceuticals Inc
- **First approval:** 2025-11-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218929)
---
*AI Analytics · CC0 1.0*